PDS Biotechnology (PDSB) Earnings Date, Estimates & Call Transcripts $3.26 -0.02 (-0.61%) (As of 01:15 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PDS Biotechnology Latest Earnings SummaryUpcoming Q3 Earnings DateNov. 14Before Market OpensConfirmedActual EPS (Aug. 13) -$0.23 Beat By $0.08 Consensus EPS (Aug. 13) -$0.31 PDS Biotechnology announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.23, which topped the consensus estimate of -$0.31 by $0.08. With a trailing EPS of -$1.22, PDS Biotechnology's earnings are expected to decrease next year, from ($1.24) to ($1.34) per share. Earnings Press ReleasePDSB Upcoming EarningsPDS Biotechnology's next earnings date is scheduled for Thursday, November 14, 2024, with a conference call scheduled for at 8:30 AM ET. Interested parties can register for or listen to the call. Get PDS Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PDS Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPDSB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PDSB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide PDS Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.40-$0.33-$0.37Q2 20241-$0.29-$0.29-$0.29Q3 20242-$0.33-$0.28-$0.31Q4 20242-$0.39-$0.34-$0.37FY 20247-$1.41-$1.24-$1.33Q1 20251-$0.37-$0.37-$0.37Q2 20251-$0.37-$0.37-$0.37Q3 20251-$0.39-$0.39-$0.39Q4 20251-$0.41-$0.41-$0.41FY 20254($1.54)($1.54)($1.54) PDS Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Confirmed)------- 8/13/2024Q2 2024-$0.31-$0.23+$0.08-$0.23-- 5/15/2024Q1 2024-$0.37-$0.30+$0.07-$0.30-- 3/27/2024Q4 2023-$0.39-$0.34+$0.05-$0.34-- 11/14/2023Q3 2023-$0.42-$0.35+$0.07-$0.35-- 8/14/2023Q2 2023-$0.37-$0.37--$0.37-- 5/15/2023Q1 2023-$0.31-$0.32 -$0.01-$0.32-- Get the Latest News and Ratings for PDSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PDS Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 3/28/2023Q4 2022-$0.30-$0.67 -$0.37-$0.67-- 11/14/2022Q3 2022-$0.26-$0.26--$0.26-- PDS Biotechnology Earnings - Frequently Asked Questions When is PDS Biotechnology's earnings date? PDS Biotechnology has confirmed that its next quarterly earnings data will be published on Thursday, November 14th, 2024. Learn more on PDSB's earnings history. Did PDS Biotechnology beat their earnings estimates last quarter? In the previous quarter, PDS Biotechnology (NASDAQ:PDSB) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.08. Learn more on analysts' earnings estimate vs. PDSB's actual earnings. How much profit does PDS Biotechnology generate each year? PDS Biotechnology (NASDAQ:PDSB) has a recorded net income of -$42.94 million. PDSB has generated -$1.22 earnings per share over the last four quarters. What is PDS Biotechnology's EPS forecast for next year? PDS Biotechnology's earnings are expected to decrease from ($1.24) per share to ($1.34) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Inovio Pharmaceuticals Earnings Results Monte Rosa Therapeutics Earnings Results Foghorn Therapeutics Earnings Results REGENXBIO Earnings Results Ginkgo Bioworks Earnings Results Contineum Therapeutics Earnings Results COMPASS Pathways Earnings Results Biomea Fusion Earnings Results 4D Molecular Therapeutics Earnings Results Neoleukin Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NASDAQ:PDSB) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedToday, I want to show you how all these warning signs are converging… and how they’re about to reach a breakin...Porter & Company | SponsoredReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDSB Stock Alerts